See also this year's filing and all EDGAR filings for this company.
PDF Report 0001694665_2019_Evelo_Biosciences_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001694665')"} |
Graph
Absolute values for 0001694665, Evelo Biosciences Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 151,622,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,925,000 |
| 3 | remainder_Assets | 1,320,000 |
| 4 | LiabilitiesCurrent | 9,235,000 |
| 5 | LiabilitiesNoncurrent | 12,612,000 |
| 6 | remainder_Liabilities | 1,071,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 18,218,000 |
| 9 | ResearchAndDevelopmentExpense | 39,885,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,157,000 |
| 13 | remainder_ComprehensiveNetIncome | -18,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 159,867,000 |
| 1 | Liabilities | 22,918,000 |
| 2 | Expenses | 58,103,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 136,949,000 |
| 5 | NetIncome | -56,946,000 |
| 6 | ComprehensiveNetIncome | -56,955,000 |
| 7 | BaseVar | 121,031,500 |
| 8 | EconomicCapitalRatio | 1.95 |